COVID-19: To wear or not to wear a mask — a disastrous public health messaging
If WHO, CDC and the U.S. Surgeon General were equally responsible for the public health message disaster of discouraging mask
Read More
Featured
Only a small proportion of children develop severe COVID-19 disease
Children (including infants) younger than 18 years generally have only mild COVID-19 disease, and deaths were less than 1%. However,
Read More
Serum Institute may manufacture 2-3 million Oxford vaccine doses in July
The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are
Read More
COVID-19: Two doses of Oxford vaccine boost immune responses in pigs
While a single dose induced antigen-specific antibody and T cells responses in pigs, the booster dose enhanced the antibody responses
Read More
‘Why I will not take the advisory on Chinese phishing campaign seriously’
An advisory from the Indian government that an email with a government email address (ncov19@gov.in) may be a phishing campaign from hackers in China appears silly, at best. That is not how phishing campaigns are carried out. Also, Chinese apps and UC browser are far more dangerous
Read More
Gilead to begin testing inhaled remdesivir for early-stage treatment
Gilead plans to begin a Phase-1 clinical trial in August of an inhaled version of remdesivir for early-stage COVID-19 treatment
Read More
How States have fared the COVID-19 fight
Unmindful of the high positive cases reported daily, Maharashtra has tested aggressively, while Delhi has done the opposite. Kerala, Karnataka
Read More
Antibodies from convalescent plasma protects against COVID-19
The researchers found passive transfer of neutralising antibodies isolated from convalescent plasma into Syrian hamsters protect the animals against the
Read More
Antibodies against coronavirus start to decrease in 2-3 months, study finds
The study found IgG levels and neutralizing antibodies started to decrease within two-three months after infection with novel coronavirus. The
Read More
In a new lockdown, a second chance for Tamil Nadu to contain coronavirus spread
With a complete lockdown for 12 days that began from June 19, Tamil Nadu has another opportunity to contain the
Read More
WHO halts hydroxychloroquine arm of Solidarity trial
About two weeks after the RECOVERY trial announced that hydroxychloroquine does not reduce deaths among hospitalised COVID-19 patients and was
Read More
Dexamethasone reduces deaths in COVID-19 patients with severe complications
The RECOVERY trial has found that the steroid dexamethasone reduces deaths by one-third in COVID-19 patients on ventilator and by
Read More
5% of COVID-19 patients admitted to a hospital died in the U.S.
A COVID-19 case surveillance between January 22-May 30 finds 5% of people admitted to a hospital died. Hospitalisation was six
Read More